The Firmwatch take
Enhanced Genomics Limited (12423696) currently shows: No major warning signs in the latest extracted accounts, based on accounts to 31 December 2024; last refreshed 24 May 2026. No distress signals. Accounts cover the period ending 31 Dec 2024.
Companies House source·Accounts to 31 Dec 2024·Refreshed 24 May 2026·Methodology and caveats
Firmwatch signals are generated from public filings and are not credit ratings or financial advice.
Incorporated
24 January 2020
6 years on the register
Sector
Scientific research and development
SIC 72110 · matched to division
Size
Not classified
Net assets
£3.7m
£3,694,275
Cash at bank
Not disclosed
Not required for this filing type
Latest filing
None yet
Insolvency risk
Low insolvency risk
The latest public accounts do not show obvious balance-sheet stress. This does not rule out trading problems, but the filed numbers look comparatively steady.
Positive net assets
The latest extracted accounts show assets exceeding liabilities.
Address pattern · CB4 0WS
341 other UK companies registered at this postcode.
Active
330
Dissolved
4
Strike-off action
7
Money
What the balance sheet says
Net assets
£3.7m
Cash
Not disclosed
Working cap.
£3.1m
Current ratio
9.9×
Signals · 1
Positive net assets
The latest filed accounts show assets exceeding liabilities.
People
Who runs this company
- PA
PARKWALK ADVISORS LTD
corporate-director · since 2022
Registered office
Address intelligence
341 other companies use this address.
High-volume registered-office service. Many UK companies use these legitimately, but they are also a known hosting location for shell entities. Treat this as a flag, not a verdict.
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.